FIBROGEN, INC.

FGEN

Delayed - 01/25 04:00:00 pm
49.59USD	+4.27%

01/08	FIBROGEN, INC. - Insider at FibroGen Sells Stock for Taxes Interrupting...
12/22	FIBROGEN, INC. - Commences Phase 3 Trial of Pamrevlumab in Idiopathic...
12/22	FIBROGEN, INC. - FibroGen Advances Phase 3 Clinical Development of...
12/21	DOW JONES 30 - Stocks Dragged Into The Red as New COVID-19 Strain From UK...
12/21	FIBROGEN, INC. - FibroGen Down, FDA Extends Review Period for Roxadustat

12/21	AGIOS PHARMACEUTICALS, INC. - Health Care Stocks Trade Lower Premarket Monday
12/21	FIBROGEN, INC. - Provides Regulatory Update on Roxadustat
12/21	FIBROGEN, INC. - Update on US regulatory review of roxadustat in anaemia of...
12/21	ASTRAZENECA PLC - FDA Requests More Analysis for Approval of Roxadustat
12/21	ASTRAZENECA PLC - US Regulator Extends Review Period For AstraZeneca's...
12/18	FIBROGEN, INC. - Other Events, Financial Statements and Exhibits (form 8-K)
12/18	FIBROGEN, INC. - Shares Down Over 11% in Late Trade
12/18	FIBROGEN, INC. - FibroGen Provides Regulatory Update on Roxadustat
12/17	FIBROGEN, INC. - FibroGen Insider Disposition Interrupting 90-Day Buy Trend
12/17	FIBROGEN, INC. - Insider Sale at FibroGen Slowing 90-Days of Buying
12/09	FIBROGEN, INC. - Insider at FibroGen Sells Stock for Taxes Interrupting...
12/09	FIBROGEN, INC. - Insider at FibroGen Sells Stock for Taxes Interrupting...
12/09	FIBROGEN, INC. - FibroGen Insider Disposes of Shares for Tax Slowing 90-Day...
12/09	FIBROGEN, INC. - FibroGen Insider Sells Shares for Tax Slowing 90-Day Buy Trend
12/02	FIBROGEN, INC. - FibroGen to Present Safety and Efficacy Analyses from...

More news